Abstract:BackgroundMethylation of high-density CpG regions known as CpG Islands (CGIs) has been widely described as a mechanism associated with gene expression regulation. Aberrant promoter methylation is considered a hallmark of cancer involved in silencing of tumor suppressor genes and activation of oncogenes. However, recent studies have also challenged the simple model of gene expression control by promoter methylation in cancer, and the precise mechanism of and role played by changes in DNA methylation in carcinogenesis remains elusive.ResultsUsing a large dataset of 672 matched cancerous and healthy methylomes, gene expression, and copy number profiles accross 3 types of tissues from The Cancer Genome Atlas (TCGA), we perform a detailed meta-analysis to clarify the interplay between promoter methylation and gene expression in normal and cancer samples. On the one hand, we recover the existence of a CpG island methylator phenotype (CIMP) with prognostic value in a subset of breast, colon and lung cancer samples, where a common subset of promoter CGIs hypomethylated in normal samples become hypermethylated. However, this hypermethylation is not accompanied by a decrease in expression of the corresponding genes, which are already lowly expressed in the normal genes. On the other hand, we identify tissue-specific sets of genes, different between normal and cancer samples, whose inter-individual variation in expression is significantly correlated with the variation in methylation of the 3’ flanking regions of the promoter CGIs. These subsets of genes are not the same in the different tissues, nor between normal and cancerous samples, but transcription factors are over-represented in all subsets.ConclusionOur results suggest that epigenetic reprogramming in cancer does not contribute to cancer development via direct inhibition of gene expression through promoter hypermethylation. It may instead modify how the expression of a few specific genes, particularly transcription factors, are associated with DNA methylation variations in a tissue-dependent manner.

Genome-wide Profiling of DNA Methylation Reveals a Class of Normally Methylated CpG Island Promoters

Association of Abnormal Methylation of CpG Islands in Promoter Domains of Multiple Tumor Suppressor Genes with Non-Small Cell Lung Cancer

Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome

Genome-wide Survey Reveals Dynamic Widespread Tissue-Specific Changes in DNA Methylation During Development

Features of Methylation and Gene Expression in the Promoter-Associated Cpg Islands Using Human Methylome Data

Genome-wide screening and functional validation of methylation barriers near promoters

Whole-genome Bisulfite Sequencing of Multiple Individuals Reveals Complementary Roles of Promoter and Gene Body Methylation in Transcriptional Regulation

Advance in the Profile of Genome CpG Islands Methylation Methods

Genome-wide DNA Methylation Patterns in Reveal Targeting to Promoter Proximal Regions

DNA methylome profiling of human tissues identifies global and tissue-specific methylation patterns

Putative Zinc Finger Protein Binding Sites Are Over-Represented in the Boundaries of Methylation-Resistant CpG Islands in the Human Genome.

Position-Defined CpG Islands Provide Complete Co-methylation Indexing for Human Genes

Methylation profiling in acute myeloid leukemia

Whole-Genome Analysis of the Methylome and Hydroxymethylome in Normal and Malignant Lung and Liver

Systematic Dna Methylation Analysis of Multiple Cell Lines Reveals Common and Specific Patterns Within and Across Tissues of Origin

Direct ChIP-bisulfite Sequencing Reveals a Role of H3K27me3 Mediating Aberrant Hypermethylation of Promoter CpG Islands in Cancer Cells.

Changes in correlation between promoter methylation and gene expression in cancer

Intermediate DNA methylation is a conserved signature of genome regulation

Dynamic DNA methylation across diverse human cell lines and tissues

CpG_MPs: Identification of CpG Methylation Patterns of Genomic Regions from High-Throughput Bisulfite Sequencing Data

Atlas of imprinted and allele-specific DNA methylation in the human body